Differential response to treatment of relapsing–remitting multiple sclerosis with IFN-&bgr;: is there a dichotomy into T-helper-1 and -17 driven disease?

By Weissert Robert  

Future Neurology, Vol. 5, Iss. 4, 2010-07 ,pp. : 481-484

Future Medicine

Access to resources Recommend Favorite

Smad7 in T cells drives T helper 1 responses in multiple sclerosis and experimental autoimmune encephalomyelitis

By Kleiter Ingo  

Brain, Vol. 133, Iss. 4, 2010-04 ,pp. : 1067-1081

Oxford University Press

Access to resources Recommend Favorite

Blood T‐cell receptor  chain transcriptome in multiple sclerosis. Characterization of the T cells with altered CDR3 length distribution

By Laplaud David‐Axel   Ruiz Catherine   Wiertlewski Sandrine  

Brain, Vol. 127, Iss. 5, 2004-05 ,pp. : 981-995

Oxford University Press

Access to resources Recommend Favorite

Glatiramer acetate-specific T-helper 1- and 2-type cell lines produce BDNF: implications for multiple sclerosis therapy

By Ziemssen T.  

Brain, Vol. 125, Iss. 11, 2002-11 ,pp. : 2381-2391

Oxford University Press

Access to resources Recommend Favorite

Autoreactive CD8 + T cells in multiple sclerosis: a new target for therapy?

By Friese Manuel A.   Fugger Lars  

Brain, Vol. 128, Iss. 8, 2005-08 ,pp. : 1747-1763

Oxford University Press

Access to resources Recommend Favorite